| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Prime Health Services is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ortho Molecular Products is a Woodstock, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CodeOne, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Lodi Memorial Hospital is a general medical and surgical hospital in Lodi, CA, with 214 beds. Survey data for the latest year available shows that 31,080 patients visited the hospital's emergency room. The hospital had a total of 7,139 admissions. Its physicians performed 2,124 inpatient and 2,140 outpatient surgeries.